Discontinued — last reported Q1 '23

Current Liabilities

Restructuring Reserve

Biogen Restructuring Reserve increased by 144.3% to $320.00M in Q3 2023 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2023

How to read this metric

An increase suggests active cost-cutting or strategic realignment, which may lead to future margin expansion but indicates current operational friction.

Detailed definition

This liability captures the estimated costs associated with formal restructuring plans, such as severance packages, faci...

Peer comparison

Common in large financial institutions undergoing digital transformation or cost-rationalization programs.

Metric ID: restructuring_reserve

Historical Data

2 periods
 Q4 '22Q3 '23
Value$131.00M$320.00M
QoQ Change+144.3%
Range$131.00M$320.00M

Frequently Asked Questions

What is Biogen's restructuring reserve?
Biogen (BIIB) reported restructuring reserve of $320.00M in Q3 2023.
What does restructuring reserve mean?
The estimated cost set aside for future business reorganization and downsizing activities.